Hewlett-Packard to enter IVUS catheter market as part of Boston Scientific/FTC deal.
This article was originally published in The Gray Sheet
Executive Summary
HEWLETT-PACKARD LICENSES BOSTON SCIENTIFIC'S IVUS CATHETERS as part of a consent agreement between Boston Scientific and the Federal Trade Commission allowing Boston Scientific to acquire Scimed and Cardiovascular Imaging Systems. The agreement settles an FTC challenge to the acquisition on the grounds that the deal would be anticompetitive in the intravascular ultrasound field ("The Gray Sheet" Jan. 23, I&W-6).